Review of Carcinoid Syndrome: what is is and how it is treated by Joel George et al (Hampshire Hospitals and Kings Healthcare Partners ENETs Centre of Excellence) Online Publication Date: 19 Jun 2023 Neuroendocrine Cancers (aka neuroendocrine neoplasms or NENs) may...
New ENETs Guidance paper for Carcinoid Syndrome & Carcinoid Heart Disease: Recommendations and Future Research Aims Carcinoid syndrome (CS) is the most frequent hormonal complication accompanying neuroendocrine neoplasms (NENs), predominantly encountered in up to...
Carcinoid Heart Disease (CHD or Hedinger syndrome), is a rare condition that affects about one in five (20%) patients who have a Neuroendocrine Cancer AND Carcinoid Syndrome (CS). The precise cause is unknown but is thought to be related to abnormally raised levels of...
April is Testicular Cancer Awareness month – Neuroendocrine Cancer of the Testes accounts for less than 1% of all testicular tumours. Diagnosis of Neuroendocrine Cancer of the Testes usually occurs following surgery or biopsy. Carcinoid Syndrome is a very rare...
April is Bowel Cancer Awareness Month: Symptoms of Neuroendocrine Cancer of the Colon (Large Bowel) may be very similar to those that occur in Bowel Cancer, and include: A persistent change in your bowel habits, including diarrhoea or constipation or a change in the...
